Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are unheard of On this malignancy compared to other lymphoid neoplasms. CHD2 Venetoclax is among the best possibilities in this example, together with patients with high-risk genomic aberrations.